Table 4.
Group | Grade 3/4 Toxicity |
---|---|
All patients [95% CI] |
11.3% [9.1, 3.9%] I 2 = 48.5% (n = 32) |
Monotherapy [95% CI] |
6.7% [3.4, 12.7%] I 2 = 48.6% (n = 9) |
Combination therapy [95% CI] |
12.3% [9.8, 15.3%] I 2 = 48.3% (n = 23) |
Group | Grade 3/4 Toxicity |
---|---|
All patients [95% CI] |
11.3% [9.1, 3.9%] I 2 = 48.5% (n = 32) |
Monotherapy [95% CI] |
6.7% [3.4, 12.7%] I 2 = 48.6% (n = 9) |
Combination therapy [95% CI] |
12.3% [9.8, 15.3%] I 2 = 48.3% (n = 23) |